Cargando…

Three-Dimensional Amide Proton Transfer-Weighted Imaging for Differentiating between Glioblastoma, IDH-Wildtype and Primary Central Nervous System Lymphoma

SIMPLE SUMMARY: Although primary central nervous system lymphoma (PCNSL) is sometimes indistinguishable from glioblastoma, isocitrate dehydrogenase (IDH)-wildtype, the role of operation on them is very different; therefore, accurate preoperative diagnosis is crucial. In this study, we evaluated whet...

Descripción completa

Detalles Bibliográficos
Autores principales: Ohba, Shigeo, Murayama, Kazuhiro, Teranishi, Takao, Kumon, Masanobu, Nakae, Shunsuke, Yui, Masao, Yamamoto, Kaori, Yamada, Seiji, Abe, Masato, Hasegawa, Mitsuhiro, Hirose, Yuichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9913574/
https://www.ncbi.nlm.nih.gov/pubmed/36765909
http://dx.doi.org/10.3390/cancers15030952
_version_ 1784885460534820864
author Ohba, Shigeo
Murayama, Kazuhiro
Teranishi, Takao
Kumon, Masanobu
Nakae, Shunsuke
Yui, Masao
Yamamoto, Kaori
Yamada, Seiji
Abe, Masato
Hasegawa, Mitsuhiro
Hirose, Yuichi
author_facet Ohba, Shigeo
Murayama, Kazuhiro
Teranishi, Takao
Kumon, Masanobu
Nakae, Shunsuke
Yui, Masao
Yamamoto, Kaori
Yamada, Seiji
Abe, Masato
Hasegawa, Mitsuhiro
Hirose, Yuichi
author_sort Ohba, Shigeo
collection PubMed
description SIMPLE SUMMARY: Although primary central nervous system lymphoma (PCNSL) is sometimes indistinguishable from glioblastoma, isocitrate dehydrogenase (IDH)-wildtype, the role of operation on them is very different; therefore, accurate preoperative diagnosis is crucial. In this study, we evaluated whether amide proton transfer-weighted (APTw) imaging was useful to distinguish PCNSL from glioblastoma, IDH-wildtype. The mean APTw signal value did not significantly differ between them; however, the percentile values from the 1st percentile to the 20th percentile APTw signals and the width(1–100) APTw signals between the two diseases were significantly different. The area under the curve, sensitivity, and specificity were 0.796, 64.3%, and 88.9%, respectively, using the width(1–100) APTw signal values. APTw imaging was useful to differentiate between PCNSL and glioblastoma, IDH-wildtype. Performing APTw imaging is recommended in cases in which PCNSL is one of the differential diagnoses. ABSTRACT: Distinguishing primary central nervous system lymphoma (PCNSL) from glioblastoma, isocitrate dehydrogenase (IDH)-wildtype is sometimes hard. Because the role of operation on them varies, accurate preoperative diagnosis is crucial. In this study, we evaluated whether a specific kind of chemical exchange saturation transfer imaging, i.e., amide proton transfer-weighted (APTw) imaging, was useful to distinguish PCNSL from glioblastoma, IDH-wildtype. A total of 14 PCNSL and 27 glioblastoma, IDH-wildtype cases were evaluated. There was no significant difference in the mean APTw signal values between the two groups. However, the percentile values from the 1st percentile to the 20th percentile APTw signals and the width(1–100) APTw signals significantly differed. The highest area under the curve was 0.796, which was obtained from the width(1–100) APTw signal values. The sensitivity and specificity values were 64.3% and 88.9%, respectively. APTw imaging was useful to distinguish PCNSL from glioblastoma, IDH-wildtype. To avoid unnecessary aggressive surgical resection, APTw imaging is recommended for cases in which PCNSL is one of the differential diagnoses.
format Online
Article
Text
id pubmed-9913574
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-99135742023-02-11 Three-Dimensional Amide Proton Transfer-Weighted Imaging for Differentiating between Glioblastoma, IDH-Wildtype and Primary Central Nervous System Lymphoma Ohba, Shigeo Murayama, Kazuhiro Teranishi, Takao Kumon, Masanobu Nakae, Shunsuke Yui, Masao Yamamoto, Kaori Yamada, Seiji Abe, Masato Hasegawa, Mitsuhiro Hirose, Yuichi Cancers (Basel) Article SIMPLE SUMMARY: Although primary central nervous system lymphoma (PCNSL) is sometimes indistinguishable from glioblastoma, isocitrate dehydrogenase (IDH)-wildtype, the role of operation on them is very different; therefore, accurate preoperative diagnosis is crucial. In this study, we evaluated whether amide proton transfer-weighted (APTw) imaging was useful to distinguish PCNSL from glioblastoma, IDH-wildtype. The mean APTw signal value did not significantly differ between them; however, the percentile values from the 1st percentile to the 20th percentile APTw signals and the width(1–100) APTw signals between the two diseases were significantly different. The area under the curve, sensitivity, and specificity were 0.796, 64.3%, and 88.9%, respectively, using the width(1–100) APTw signal values. APTw imaging was useful to differentiate between PCNSL and glioblastoma, IDH-wildtype. Performing APTw imaging is recommended in cases in which PCNSL is one of the differential diagnoses. ABSTRACT: Distinguishing primary central nervous system lymphoma (PCNSL) from glioblastoma, isocitrate dehydrogenase (IDH)-wildtype is sometimes hard. Because the role of operation on them varies, accurate preoperative diagnosis is crucial. In this study, we evaluated whether a specific kind of chemical exchange saturation transfer imaging, i.e., amide proton transfer-weighted (APTw) imaging, was useful to distinguish PCNSL from glioblastoma, IDH-wildtype. A total of 14 PCNSL and 27 glioblastoma, IDH-wildtype cases were evaluated. There was no significant difference in the mean APTw signal values between the two groups. However, the percentile values from the 1st percentile to the 20th percentile APTw signals and the width(1–100) APTw signals significantly differed. The highest area under the curve was 0.796, which was obtained from the width(1–100) APTw signal values. The sensitivity and specificity values were 64.3% and 88.9%, respectively. APTw imaging was useful to distinguish PCNSL from glioblastoma, IDH-wildtype. To avoid unnecessary aggressive surgical resection, APTw imaging is recommended for cases in which PCNSL is one of the differential diagnoses. MDPI 2023-02-02 /pmc/articles/PMC9913574/ /pubmed/36765909 http://dx.doi.org/10.3390/cancers15030952 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Ohba, Shigeo
Murayama, Kazuhiro
Teranishi, Takao
Kumon, Masanobu
Nakae, Shunsuke
Yui, Masao
Yamamoto, Kaori
Yamada, Seiji
Abe, Masato
Hasegawa, Mitsuhiro
Hirose, Yuichi
Three-Dimensional Amide Proton Transfer-Weighted Imaging for Differentiating between Glioblastoma, IDH-Wildtype and Primary Central Nervous System Lymphoma
title Three-Dimensional Amide Proton Transfer-Weighted Imaging for Differentiating between Glioblastoma, IDH-Wildtype and Primary Central Nervous System Lymphoma
title_full Three-Dimensional Amide Proton Transfer-Weighted Imaging for Differentiating between Glioblastoma, IDH-Wildtype and Primary Central Nervous System Lymphoma
title_fullStr Three-Dimensional Amide Proton Transfer-Weighted Imaging for Differentiating between Glioblastoma, IDH-Wildtype and Primary Central Nervous System Lymphoma
title_full_unstemmed Three-Dimensional Amide Proton Transfer-Weighted Imaging for Differentiating between Glioblastoma, IDH-Wildtype and Primary Central Nervous System Lymphoma
title_short Three-Dimensional Amide Proton Transfer-Weighted Imaging for Differentiating between Glioblastoma, IDH-Wildtype and Primary Central Nervous System Lymphoma
title_sort three-dimensional amide proton transfer-weighted imaging for differentiating between glioblastoma, idh-wildtype and primary central nervous system lymphoma
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9913574/
https://www.ncbi.nlm.nih.gov/pubmed/36765909
http://dx.doi.org/10.3390/cancers15030952
work_keys_str_mv AT ohbashigeo threedimensionalamideprotontransferweightedimagingfordifferentiatingbetweenglioblastomaidhwildtypeandprimarycentralnervoussystemlymphoma
AT murayamakazuhiro threedimensionalamideprotontransferweightedimagingfordifferentiatingbetweenglioblastomaidhwildtypeandprimarycentralnervoussystemlymphoma
AT teranishitakao threedimensionalamideprotontransferweightedimagingfordifferentiatingbetweenglioblastomaidhwildtypeandprimarycentralnervoussystemlymphoma
AT kumonmasanobu threedimensionalamideprotontransferweightedimagingfordifferentiatingbetweenglioblastomaidhwildtypeandprimarycentralnervoussystemlymphoma
AT nakaeshunsuke threedimensionalamideprotontransferweightedimagingfordifferentiatingbetweenglioblastomaidhwildtypeandprimarycentralnervoussystemlymphoma
AT yuimasao threedimensionalamideprotontransferweightedimagingfordifferentiatingbetweenglioblastomaidhwildtypeandprimarycentralnervoussystemlymphoma
AT yamamotokaori threedimensionalamideprotontransferweightedimagingfordifferentiatingbetweenglioblastomaidhwildtypeandprimarycentralnervoussystemlymphoma
AT yamadaseiji threedimensionalamideprotontransferweightedimagingfordifferentiatingbetweenglioblastomaidhwildtypeandprimarycentralnervoussystemlymphoma
AT abemasato threedimensionalamideprotontransferweightedimagingfordifferentiatingbetweenglioblastomaidhwildtypeandprimarycentralnervoussystemlymphoma
AT hasegawamitsuhiro threedimensionalamideprotontransferweightedimagingfordifferentiatingbetweenglioblastomaidhwildtypeandprimarycentralnervoussystemlymphoma
AT hiroseyuichi threedimensionalamideprotontransferweightedimagingfordifferentiatingbetweenglioblastomaidhwildtypeandprimarycentralnervoussystemlymphoma